Atrial fibrillation is the most common sustained cardiac dysrhythmia. It represents a major public health problem due to increased mortality risk, reduced quality of life, and increased health costs [1, 2]. The prevalence of nonvalvular atrial fibrillation (AF) continues to increase worldwide, largely affecting the elderly, but also occurring in younger patients as a result of structural heart disease, autonomic imbalance, genetic abnormality, or previous cardiac surgery [3]. The rise in prevalence of AF is largely due to the increasing age of the population. About 1–2% of the total population is affected by AF, but the prevalence of this condition rises to ≈ 10% in individuals aged > 75 years [1, 2, 3]. In Europe, the number of adults with AF is rising markedly, with 9 million affected individuals in 2010, and 17 million expected patients in 2050, with an alarming impact on morbidity and mortality [4]. The associated fivefold risk of stroke is one of the most feared complications of... This is a preview of subscription content,...

Mulè', G., Carollo, C., Guarneri, M., Cottone, S. (2018). The changing landscape of thromboprophylaxis for atrial fibrillation: insights from the ISPAF-2 survey. INTERNAL AND EMERGENCY MEDICINE([Epub ahead of print] 2018 Aug 16. doi: 10.1007/s11739-018-1929-4.), 1-3 [10.1007/s11739-018-1929-4].

The changing landscape of thromboprophylaxis for atrial fibrillation: insights from the ISPAF-2 survey

Mulè', Giuseppe
;
Carollo, Caterina;Guarneri, Marco;Cottone, Santina
2018-01-01

Abstract

Atrial fibrillation is the most common sustained cardiac dysrhythmia. It represents a major public health problem due to increased mortality risk, reduced quality of life, and increased health costs [1, 2]. The prevalence of nonvalvular atrial fibrillation (AF) continues to increase worldwide, largely affecting the elderly, but also occurring in younger patients as a result of structural heart disease, autonomic imbalance, genetic abnormality, or previous cardiac surgery [3]. The rise in prevalence of AF is largely due to the increasing age of the population. About 1–2% of the total population is affected by AF, but the prevalence of this condition rises to ≈ 10% in individuals aged > 75 years [1, 2, 3]. In Europe, the number of adults with AF is rising markedly, with 9 million affected individuals in 2010, and 17 million expected patients in 2050, with an alarming impact on morbidity and mortality [4]. The associated fivefold risk of stroke is one of the most feared complications of... This is a preview of subscription content,...
2018
Mulè', G., Carollo, C., Guarneri, M., Cottone, S. (2018). The changing landscape of thromboprophylaxis for atrial fibrillation: insights from the ISPAF-2 survey. INTERNAL AND EMERGENCY MEDICINE([Epub ahead of print] 2018 Aug 16. doi: 10.1007/s11739-018-1929-4.), 1-3 [10.1007/s11739-018-1929-4].
File in questo prodotto:
File Dimensione Formato  
The changing landscape of thromboprophylaxis for AF con COVER, IEM 18.pdf

Solo gestori archvio

Dimensione 834.37 kB
Formato Adobe PDF
834.37 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/295302
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact